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QRS Width and Mechanical Dyssynchrony for Selection
of Patients for Cardiac Resynchronization Therapy
One Can’t Do Without the Other*
Theodore P. Abraham, MD, Niels Thue Olsen, MD
Baltimore, MarylandCardiac resynchronization therapy (CRT) in patients
with therapy-resistant, symptomatic heart failure in
the setting of reduced left ventricular (LV) ejection
fraction and wide QRS complex provides symptom
relief, induces reverse remodeling, and improves sur-
vival (1–3). Because approximately 30% of patients
fulfilling standard selection criteria for CRT do not
experience such benefits, there has been substantial
interest in identifying a method or parameter that
predicts which patient would respond best to CRT.
See page 132
The biological value of CRT is believed to be the
synchronization of dyssynchronous mechanical con-
traction of the LV, associated with progressive dilation
and electrical remodeling of heart failure. “Dyssyn-
chrony imaging” has emerged as a widely branching
research area, with a multitude of publications (4–7)
encompassing several methods. Characteristic of the
research has been an attempt to substitute mechanical
dyssynchrony for QRS duration as a selection criterion
for CRT. These efforts have lately been met with
skepticism despite the barrage of apparently useful
tissue Doppler (velocity) imaging (TDI)-based pa-
rameters as the result of 2 key studies, the RethinQ
(Resynchronization Therapy in Narrow QRS) study
and the PROSPECT (Predictors of Response to
CRT) study (8,9). Both studies indicated that TDI-
based parameters were not useful in identifying pa-
tients who would benefit most from CRT. Technical
and interpretative difficulties with current TDI-based
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.From the Division of Cardiology, Johns Hopkins University, Baltimore,
Maryland.echocardiography methods were implicated in the
PROSPECT trial. In the RethinQ study, patients
with narrow QRS duration, identified with echocar-
diography as having mechanical dyssynchrony, were
randomized to CRT versus no CRT. The outcomes
were similar in both groups, suggesting that TDI-
based patient selection in a narrow QRS cohort may
not be clinically useful.
In this regard, in this issue of iJACC, Oyenuga et al.
(10) re-examine the issue of patient selection in heart
failure patients with borderline QRS duration. They
evaluated a relatively large group of CRT patients (n 
187), a significant proportion of whom had a borderline
QRS duration (n  72, mean QRS duration for this
group was 115 ms). The entire cohort was subjected to
extensive dyssynchrony evaluation by the use of a number
of previously published dyssynchrony parameters that
were applied to stored baseline images. Response to
CRT was adjudicated on the basis of an improvement in
ejection fraction and reverse remodeling as assessed by
repeat echocardiography several months after device im-
plant (mean 8 months).
Significantly fewer patients with a borderline QRS
duration (53%) demonstrated a response to CRT com-
pared with the wide QRS patients (75%). Interventric-
ular dyssynchrony by pulsed-wave Doppler (interventric-
ular mechanical delay) was more prevalent in the wide
QRS compared with the borderline QRS patients (54%
vs. 18%, respectively). In contrast, previously reported
TDI-based indexes of intraventricular dyssynchrony
(longitudinal opposing wall delay and the Yu index) were
similar in both groups. Speckle tracking-based time to
peak radial strain (septal to posterior wall) was noted
significantly less frequently in the borderline QRS com-
pared with the wide QRS group (47% vs. 71%, respec-
tively). Interventricular delay and TDI-based intraven-
tricular indexes predicted ejection fraction improvement
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142nly in the wide QRS group. However, septal to poste-
ior radial strain delay by speckle tracking performed
qually well in both groups, with an area under the curve
f 0.79 in the wide QRS and 0.83 in the borderline QRS
atients.
The results highlight and support important concepts.
irst, the prevalence of CRT responders increases with
RS width. Most heart failure patients with QRS
uration  150 ms have mechanical dyssynchrony, and
he benefits from CRT in this population are unques-
ionable. Fewer patients with a QRS duration between
20 and 150 ms seem to benefit from CRT. In the large
OMPANION (Comparison of Medical Therapy,
acing, and Defibrillation in Heart Failure) trial (2), the
rimary end point was only met in the pre-defined
ubgroup of patients with QRS duration 148 ms, and
n the newer REVERSE (Resynchronization Reverses
emodeling in Systolic Left Ventricular Dysfunction)
11) and MADIT-CRT (Multicenter Automatic Defi-
rillator Implantation Trial-Cardiac Resynchronization
herapy) trials (12), the effect of CRT was primarily
bserved in patients with QRS duration 152 and 150
s, respectively. The multicenter RethinQ study (8) of
atients with QRS duration  130 ms, which also
ncluded only patients with echocardiographic dyssyn-
hrony, did not meet its primary end point, and only the
mall pre-defined subgroup with a QRS duration be-
ween 120 and 130 ms objectively benefited from CRT.
n contrast to these findings, and in accordance with the
urrent findings by Oyenuga et al. (10), patients with a
RS duration  120 ms have, in single-center studies
n echocardiographically carefully selected patients, been
hown to benefit from CRT (13,14).
Second, the character of mechanical dyssynchrony
epends on QRS width. The mechanics of dilated heart
ailure with a very wide left bundle branch block-type
RS complex exhibits both interventricular and intra-
entricular dyssynchrony, whereas interventricular dys-
ynchrony is rare in patients with QRS duration below
30 ms. In heart failure with a more narrow QRS
omplex, LV wall motion homogeneities often may be
elated to myocardial abnormalities not related to elec-
rical activation, which presumably are not markers for
RT response, and echocardiographic methods differ in
heir ability to discriminate true timing differences from
hese effects. Methods based on time-to-peak myocardial
elocity may in this respect be less specific than strain-
ased methods, and the implications of the RethinQ
tudy need to be reconsidered in this light.
Collectively, these arguments lead to the realization
hat QRS width to a great degree determines the poten-
ial application of echocardiographic dyssynchrony eval- mation. In patients with QRS duration 150 ms, despite
he large number of studies on its predictive power in this
opulation, echocardiographic dyssynchrony evaluation
ill probably play only a limited role in selecting patients
or CRT. It is very difficult to improve on the large a
riori chance of success in this group, and considering the
mpact of other factors than mechanical dyssynchrony on
esponse, it is unlikely any echocardiographic method
ould add important value to patient selection. In pa-
ients with QRS duration of 120 to 150 ms, echocardi-
graphy is potentially valuable to avoid treating likely
onresponders. This strategy was followed in the
ARE-HF (Cardiac Resynchronization in Heart Fail-
re) trial (3), where patients with this QRS range had to
ave echocardiographic evidence of dyssynchrony to be
ncluded. Because these patients currently have a class IA
ndication for CRT, and the prevalence of potential
esponders is probably at least moderate, the echocardio-
raphic method must be very sensitive to avoid denying
reatment due to false-negative results. In patients with
RS duration  120 ms, however, the prevalence of
otential CRT responders can be expected to be low or
ven very low. In such a population, the accurate identi-
cation of the rare potential responder becomes all-
mportant, and a high specificity of the echocardio-
raphic method is imperative to avoid treating a large
umber of false positives.
The data from Oyenuga et al. (10) suggest that radial
train-derived mechanical delays may be an efficient way
o identify such patients. This work supplements and
ppears to validate previous work published by this group
n radial strain. If duplicated in a larger, randomized
ulticenter cohort, clinical application of radial strain for
atient selection would be subject to some cautions.
adial strain measurement is “noisier” and therefore
ssociated with more variability than longitudinal or
ircumferential strain (15,16). Selection of an appropriate
ample width while applying the region of interest
ppears to influence timing and amplitude of radial
train. Standardization in this regard would be useful in
educing variability and consequent loss of accuracy.
ultiple peaks and biphasic peaks occur often in the
eart failure population, and there is no clear agreement
n how best to adjudicate them. Finally, severely hypo-
inetic or akinetic regions have very low or absent strain,
nd dyssynchrony measurement may be challenging if
ot impossible.
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